Physician profile
Leo P Sullivan
NPI 1437140472
$1,478.45
in general payments reported to CMS, 2019-2025
21 companies · $274 in 2025
The $274 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $161 · 2020: $21.25 · 2021: $279 · 2022: $90.21 · 2023: $180 · 2024: $473 · 2025: $274.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $927.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $926.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lemaitre Vascular, INC. | $198.53 | 2019-2025 | Hydro Lemaitre Valvulotome, Artegraft Vascular Graft |
| Smith+Nephew, INC. | $196.76 | 2019-2024 | Grafix Pl, Collagenase Santyl, Oasis |
| Organogenesis INC. | $141.04 | 2024-2025 | Puraply Am, Apligraf, Puraply Wound Matrix |
| Tela Bio, INC. | $134.19 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Depuy Synthes Sales INC. | $89.72 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $89.22 | 2022-2023 | Seglentis |
| Pfizer INC. | $87.65 | 2023-2025 | |
| Bard Peripheral Vascular, INC. | $78.74 | 2021-2023 | Venclose Maven Catheter |
| Medtronic, INC. | $65.95 | 2024-2025 | Venaseal, Closurerfs |
| Stryker Corporation | $60.23 | 2021 | |
| Tactile Systems Technology INC | $55.35 | 2019-2025 | Nimbl, Flexitouch Plus |
| Baxter Healthcare | $47.10 | 2021-2024 | Coseal |
| Cook Medical LLC | $44.47 | 2023-2025 | Cook |
| Portola Pharmaceuticals, LLC | $40.42 | 2019 | |
| Kerecis Limited | $29.74 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acelrx Pharmaceuticals, INC. | $27.44 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $25.20 | 2024 | Exparel |
| Z-Medica, LLC | $18.01 | 2019 | |
| Terumo Medical Corporation | $17.87 | 2023 | Azur Cx Detachable |
| Paratek Pharmaceuticals, INC. | $16.72 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $14.10 | 2023 | Eliquis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leo Sullivan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.